GlassScriptPhysician profile
Jessica Mao
NPI 1588195291
$113,656.37
in general payments reported to CMS, 2019-2025
6 companies · $103K in 2025
The $103K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $108 · 2024: $10K · 2025: $103K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $110K · Food and Beverage: $2,841 · Education: $814 · Travel and Lodging: $1.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $110,000.00 |
| Food and Beverage | $2,840.57 |
| Education | $813.88 |
| Travel and Lodging | $1.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $76,538.95 | 2024-2025 | Emblem Mri S-Icd, Accolade Sr, Farapulse |
| Medtronic, INC. | $36,099.16 | 2023-2025 | Aurora Ev-Icd Mri Surescan, Micra, Onyx Frontier |
| Biosense Webster, INC. | $568.26 | 2024-2025 | Carto 3 |
| Shockwave Medical, INC | $150.00 | 2025 | |
| Abiomed | $150.00 | 2025 | |
| Cvrx, INC. | $150.00 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Mao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.